Runming Jin
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- General Dentistry top 10%
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 12
- Platelet Disorders and Treatments 4
-
- Acute Lymphoblastic Leukemia research 30
- Co-authors
- Hongbo Chen (14 shared papers)Yuxi Wen (9 shared papers)Fen Zhou (13 shared papers)Xiaoyan Wu (5 shared papers)Zhiquan Zhang (7 shared papers)Heng Mei (9 shared papers)Leike Zhang (4 shared papers)Gengfu Xiao (4 shared papers)
- Journals
- World Journal of Pediatrics (7 papers)Leukemia Research (3 papers)Frontiers in Oncology (3 papers)Frontiers in Immunology (3 papers)Cancer Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Runming Jin
112 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 142
- Infectious Diseases 945
- General Dentistry 8
- Modeling and Simulation 85
- Public Health, Environmental and Occupational Health 554
- Oncology 328
Countries citing papers authored by Runming Jin
This map shows the geographic impact of Runming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runming Jin more than expected).
Fields of papers citing papers by Runming Jin
This network shows the impact of papers produced by Runming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runming Jin. The network helps show where Runming Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Runming Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 588 | |
| 2 | 2020 | 296 | |
| 3 | 2020 | 252 | |
| 4 | 2016 | 215 | |
| 5 | 2020 | 179 | |
| 6 | 2020 | 116 | |
| 7 | 2019 | 112 | |
| 8 | 2020 | 109 | |
| 9 | 2009 | 105 | |
| 10 | 2018 | 95 | |
| 11 | 2021 | 95 | |
| 12 | 2019 | 72 | |
| 13 | 2021 | 65 | |
| 14 | 2021 | 63 | |
| 15 | 2020 | 61 | |
| 16 | 2019 | 52 | |
| 17 | 2008 | 50 | |
| 18 | 2017 | 47 | |
| 19 | 2009 | 46 | |
| 20 | 2021 | 37 |
About Runming Jin
Runming Jin is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Infectious Diseases, Oncology and Immunology, having authored 116 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (30 papers), Acute Myeloid Leukemia Research (12 papers), COVID-19 Clinical Research Studies (11 papers), CAR-T cell therapy research (5 papers), Ion Transport and Channel Regulation (5 papers), Platelet Disorders and Treatments (4 papers), Immunotherapy and Immune Responses (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). The work is most often cited by research in Infectious Diseases (945 citations), General Dentistry (8 citations), Modeling and Simulation (85 citations), Public Health, Environmental and Occupational Health (554 citations) and Oncology (328 citations). Runming Jin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongbo Chen, Yuxi Wen, Fen Zhou, Xiaoyan Wu, Zhiquan Zhang, Heng Mei, Leike Zhang, Gengfu Xiao, Weijuan Shang and Yan Wu. Their work appears in journals such as World Journal of Pediatrics, Leukemia Research, Frontiers in Oncology, Frontiers in Immunology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.